CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - Preliminary results

Archives of Medical Science

Volumn 8, Issue 3, 2012, Pages 504-508

  Szubert, Maria ^a   Suzin, Jacek ^a   Wierzbowski, Tomasz ^a   Kowalczyk Amico, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Endometriosis; Infertility; Laparoscopy; Pelvic pain

Indexed keywords

C REACTIVE PROTEIN; CA 125 ANTIGEN; INTERLEUKIN 1BETA; VASCULOTROPIN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; FEMALE; FEMALE INFERTILITY; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; MENSTRUATION; OVARY CYST; PELVIS PAIN SYNDROME; PERITONEAL FLUID; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 84863916455     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.29529     Document Type: Article

References (21)

1. Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA-125 is encoded by the MUC16 mucin gene. Int J Cancer 2002; 98: 737-40. (Pubitemid 34225625)
2. Nowak-Markwitz E, Michalak M, Spaczyński M. Prediction value of serum Ca 125 level in benefit secondary cytoreduction in advanced ovarian cancer patients. Współcz Onkol 2003; 7: 662-7.
3. Berek JS, Taylor PT, Nicodemus CF. CA-125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer. J Immunother 2008; 31: 207-14.
4. Muyldermans M, Cornillie FJ, Koninckx PR. CA-125 and endometriosis. Hum Reprod Update 1995; 1: 173-87.
5. Wilczak M, Rzymski P, Stryjakowska K, Stanek R, Opala T. Highly elevated levels of the antigen Ca-125 associated with inflammatory abdominal masses. Arch Med Sci 2007; 3: 278-80. (Pubitemid 47621678)
6. Kennedy S, Bergqvist A, Charon C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005; 20: 2698-704. (Pubitemid 41487622)
7. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod 1991; 6: 544-9.
8. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004; 160: 784-96. (Pubitemid 39362216)
9. Child TJ, Tan SL. Endometriosis: aetiology, pathogenesis and treatment. Drugs 2001; 61: 1735-50.
10. Barbosa CP, de Souza AM, Bianco B, Christofolini DM, Mafra FA, de Lima GR. OC-125 immunostaining in endometriotic lesion samples. Arch Gynecol Obstet 2009; 281: 43-7.
11. Spaczynski RZ, Duleba AJ. Diagnosis of endometriosis. Semin Reprod Med 2003; 21: 193-208.
12. Mol BW, Bayram N, Lijmer J G, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998; 70: 1101-8. (Pubitemid 28546238)
13. Abrão MS, Podgaec S, Filho BM, Ramos LO, Pinotti JA, de Oliveira RM. The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod 1997; 12: 2523-7.
14. Mihalyi A, Gevaert O, Kyama CM, et al. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod 2010; 25: 654-64.
15. Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta 2004; 340: 41-56. (Pubitemid 38167507)
16. Kitawaki J, Ishihara H, Koshiba H, et al. Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas. Hum Reprod 2005; 20: 1999-2003. (Pubitemid 40932390)
17. Górski J, Szyłło K, Banasik M, Lewkowicz P, Tchórzewski H. CD4+, CD8+ and CD4+CD25+ T lymphocytes in peripheral blood and peritoneal fluid of women with endometriosis - preliminary report. Arch Med Sci 2007; 3: 37-42. (Pubitemid 46640375)
18. Kajihara H, Yamada Y, Kanayama S, et al. New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol 2011; 2: 73-9.
19. Velasco I, Acién P, Campos A, Acién MI, Ruiz-Maciá E. Interleukin- 6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol 2010; 84: 199-205.
20. Kraśnicki D. Serum and peritoneal fluid CA-125 concentration in women with endometriosis. Ginekol Pol 2001; 72: 1365-9.
21. Amaral VF, Ferriani RA, Sá MF, et al. Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis. Sao Paulo Med J 2006; 124: 223-7. (Pubitemid 44739595)